期刊文献+

源于补肾中药及其复方的抗骨质疏松活性成分及机制的研究 被引量:1

Study on anti-osteoporosis constituents and mechanism from Chinese traditional medicines and formulas with the effect of tonifying the kidney
下载PDF
导出
摘要 目的对作者研究组多年来从补肾中药、药食两用药材及复方中寻找抗骨质疏松活性成分的研究结果进行总结,为进一步研究提供参考依据。方法应用成骨细胞、破骨细胞、PTH诱导的骨吸收培养系统筛选及活性追踪,应用动物体内实验确证活性部位。用各种化学手段分得活性成分,用细胞培养和E lisa的方法研究其作用机制。结果通过以上研究,得到了一系列抗骨质疏松活性成分,并为药食两用药材和临床验方的抗骨质疏松应用提供依据。 Objective The research results on anti-osteoporosis chemical constituents and their mechanism from Chinese traditional medicines and formulas with tonifying the kidney were summarized,which was done by our group for some years.The paper could provide the references for the further research.Methods Osteoblast,osteoclast and bone resorption system induced by PTH were used for activity screening and bioassay guiding fractionation.The active fraction was determined by in vivo experiment and then chemical constituents were isolated by a series of chemical methods.Finally,the mechanism of the active compounds was studied by cell culture and Elisa method.Results and Conclusions A series of active constituents were obtained and the research results provided the evidences for clinical usage of food herbs and formulas.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2011年第8期663-667,共5页 Journal of Shenyang Pharmaceutical University
关键词 补肾 活性部位 活性成分 骨质疏松症 成骨细胞 破骨细胞 tonifying the kidney active fraction active constituent osteoporosis osteoblasts osteoclast
  • 相关文献

参考文献18

  • 1叶山东.骨质疏松症的诊断和治疗[J].国外医学(老年医学分册),2000,21(1):8-11. 被引量:7
  • 2赵金秀,周学瀛.骨质疏松症的遗传基础[J].国外医学(老年医学分册),1997,18(4):164-166. 被引量:3
  • 3张骁 张韬 束梅英.骨质疏松症的治疗与展望.医药经济信息,1998,:17-21.
  • 4YIN Jun, TEZUKA Y, KOUDA K, et al. Antiosteopo- rotic activity of the water extract of Dioscorea spon- giosa [ J ]. Biological & Pharmaceutical Bulletin,2004, 27 (4) :583 - 586.
  • 5殷军,刘志惠,王勇,陈英杰,门田重利.绵萆薢中两个新二芳基庚酮类化合物的分离和结构鉴定[J].中国现代中药,2006,8(2):16-19. 被引量:9
  • 6YIN Jun, KOUDA K, TEZUKA Y, et al. Steroidal gly- cosides from the rhizomes of Dioscorea spongiosa [J ]. Joumal of Natural Products, 2003,66 ( 5 ) : 646 - 650.
  • 7YIN Jun, KOUDA K, TEZUKA Y, et al. New diaryl- heptanoids from the rhizomes of Dioscorea spongiosa and their anti-osteoporotic activity[ J].Planta Medica, 2004,70( 1 ) :54 -58.
  • 8YIN Jun, TEZUKA Y, KOUDA K, et al. In vivo an- tiosteoporotic activity of a fraction of Dioscorea spon- giosa and its constituent, Methyl protodioscin [J ]. Planta Medica, 2004,69 (3) : 220 - 226.
  • 9YIN Jun, HAN Na, LIU Zhi-hui, et al. The in vitro antiosteoporotic activity of some diarylheptanoids and lignans from the rhizomes of Dioscorea spongiosa []. Planta Medica,2008,74(12) ,1451 -1453.
  • 10YIN Jun, LIU Yang, LIU Zhi-hui, et al. Steroidal Gly- cosides from Dioscorea septemloba and their inhibito-ry activity on bone resorbing [J ]. Asian Journal of Traditional Medicines ,2006,1 ( 3/4), 155 - 158.

二级参考文献29

  • 1[1]Kawasaki T,Yamauchi T,Yamauchi R.Kikuba-saponin:saponins of Japanese Dioscoreaceae[J].Chem.Pharm.Bull,1962,10(8):698-702.
  • 2[4]Craveriro AA,Prado AC,Gottlieb OR,et al.Diarylheptanoids of Centrolobium species[J].Phytochemistry,1970,9(8):1896-1875.
  • 3[5]Ohtani I,Kusumi T,Kashman Y,et al.High-field FT NMR application of Mosher,s method.The absolute configuration of marine terpenoids[J].J Am Chem Soc,1991,113(11):4092-4096.
  • 4[6]Abe F,Yamauchi T.9α-Hydroxypiperitol,9α-hydroxymedioresinol and related lignans from Alamanda Neriifolia[J].Phytochemistry,1988,27(2):575-577.
  • 5[7]Abe F,Yahara S,Kubo K,et al.Studies on Xanthoxylum spp.2.Constituents of the bark of Xanthoxylum piperitum DC[J].Chem Pharm Bull,1974,22(11):2650-2655.
  • 6[8]Chiung YM,Hayashi H,Otani T,et al.New metabolites tetrahydrofuran lignans produced by Streptomyces sp.IT-44[J].J Antibiot,1994,47(4):487-491.
  • 7Gambort SR, Sehultz BM, Handy RC et al. Osteoporosis:clinical features, prevention and treatment. Endoerionol Metab Clin North Am. 1995;24:317~371
  • 8Kanis JS. Melton LJ. Christiansen C et al. The diagnosis of osteoporosis. J Bone Miner Res, 1994;9:1137~1141
  • 9WHO Technical Report Series 843: Assessment of fracture and its application to screening for postmenopausal osteoporosis.Genera:World Health Ognization,1994
  • 10Taxel P. Osteoporosis: detection, prevention and treatment in primary care. Geriatrics, 1998;53:22~40

共引文献16

同被引文献2

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部